# FDA Inspection 1062724 - Eversight Illinois, Bloomington - July 24, 2018

Source: https://www.keypedia.com/records/fda_inspections/eversight-illinois-bloomington/edaca621-ab70-4779-8456-e1b641ba50c8
Source feed: FDA_Inspections

> FDA Inspection 1062724 for Eversight Illinois, Bloomington on July 24, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062724
- Company Name: Eversight Illinois, Bloomington
- Inspection Date: 2018-07-24
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1062724 - 2018-07-24](https://www.keypedia.com/records/fda_inspections/eversight-illinois-bloomington/3c1be5f0-05a3-42cd-adcd-8b85482479d2)
- [FDA Inspection 968469 - 2016-04-14](https://www.keypedia.com/records/fda_inspections/eversight-illinois-bloomington/d6a322c0-8232-436e-bd47-81a763b6cd78)
- [FDA Inspection 640987 - 2010-01-27](https://www.keypedia.com/records/fda_inspections/eversight-illinois-bloomington/a93ce8d7-9b95-41e9-9002-5717f1a60d50)
- [FDA Inspection 557227 - 2009-01-29](https://www.keypedia.com/records/fda_inspections/eversight-illinois-bloomington/64d7d76a-b063-47f0-83b7-52a33f357e91)

Company: https://www.keypedia.com/companies/eversight-illinois-bloomington/4cbc5c38-d491-486b-ac0b-80563f24a19f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d